VivoSeq
Other

Laparoscopic Abdominal Surgery

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Laparoscopic Abdominal Surgery is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Unknown status3 · 50%
Not yet recruiting1 · 17%
Recruiting1 · 17%
Completed1 · 17%

Clinical Trials

Trial Activity

6 trials

Intrathecal Morphine for Postoperative Analgesia in Major Laparoscopic Abdominal Surgery, a IMPACT-Scope Trial
Recruiting·FFirst Affiliated Hospital, Sun Yat-Sen University·Phase 4·NCT06666985·700 enrolled
Effect of Low-dose Pregabalin Retard (82.5 mg) Versus Standard-dose Pregabalin Retard (165 mg) on Postoperative Pain and Opioid Consumption After Elective Laparoscopic Abdominal Surgery: a Randomized, Double-blind, Controlled Trial
Not yet recruiting·SSouth Egypt Cancer Institute·N/A·NCT07456761·80 enrolled
Comparative Study on Postoperative Analgesia With Transversus Abdominis Plane Block to Local Anesthetic Infiltration With Ropivacaine in Laparoscopic Abdominal Surgery
Completed·NNational Academy of Medical Sciences, Nepal·N/A·NCT05995301·100 enrolled
Postoperative Analgesia in Laparoscopic Abdominal Surgery After Exparel Via TAP or Local Infiltration
Unknown status·UUniversity of Washington·N/A·NCT03927326·150 enrolled
Effects of Sugammadex and Conventional Reversal on Lung Function in Laparoscopic Abdominal Surgery
Unknown status·RRhendra Hardy Mohamad Zaini·N/A·NCT06210165·80 enrolled
Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery
Unknown status·—·Phase 4·NCT01819961·50 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)